Ryan Paul will explore the current role of insulin in the treatment pathway for Type 2 Diabetes, particularly in the context of newer agents such as GLP-1 receptor agonists and SGLT-2 inhibitors.
The session will provide an overview of available insulin options, offer practical guidance on initiating insulin therapy and titrating doses, and discuss how to select the most appropriate insulin products based on individual patient needs.
As always, we will answer as many questions as possible during this session.
Presenter
Ryan Paul
Ryan is an endocrinologist at Te Whatu Ora Waikato and is an Associate Professor of Medicine at the University of Waikato. He is also an honorary Senior Lecturer at the University of Auckland and a Clinical Associate of the Maurice Wilkins Centre. He is the Immediate Past-President of the New Zealand Society of Endocrinology (NZSE) and is an Executive Member of the New Zealand Society for the Study of Diabetes (NZSSD). Ryan has created the Advanced Diabetes Management Course for all health professionals in Primary Care and was awarded the NZ Medical Educator of the year in 2019.
Supported by an unrestricted educational grant from:
